Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    17564637 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Withdrawn Pilot Trial to Assess Effect of CNI Conversion of Efalizumab on T Reg Cells
Condition: Autoimmune Diseases
Intervention: Drug: Efalizumab

Indicates status has not been verified in more than two years